首页> 中文期刊>中山大学学报(医学科学版) >胰岛素/维生素B12-透明质酸纳米粒的制备及口服给药体内外性质的评价

胰岛素/维生素B12-透明质酸纳米粒的制备及口服给药体内外性质的评价

     

摘要

[目的]维生素B12修饰的透明质酸纳米粒口服递送胰岛素的体内外性质评价.[方法]采用二次乳化法制备载胰岛素/维生素B12修饰透明质酸纳米粒(INS/VB12-HA NP),激光粒度分析仪测定纳米粒粒径和分布,反相高效液相法测定纳米粒包封率和载药量;并用人结肠腺癌细胞(Caco-2)单层膜模型体外评价INS/VB12-HA NP的细胞摄取与跨膜转运;以糖尿病模型大鼠降血糖实验评价口服INS/VB12-HA NP的药效.[结果]所制备的INS/VB12-HA NP粒径在185 ~286 nm之间,PDI小于0.25,包封率在55%左右.细胞摄取实验表明在25~ 200 μg/mL胰岛素浓度范围内和孵育0.5 h后Caco-2细胞对INS/VB12-HA NP的摄取量显著高于胰岛素溶液组.Caco-2细胞单层膜跨膜转运实验中,4h内跨膜电阻没有明显变化,VB12-HA NP组比对照溶液组有更多的胰岛素跨膜量和更快的跨膜速率.糖尿病大鼠的降糖实验显示,与口服胰岛素溶液相比,纳米粒组均有显著的口服降血糖作用.[结论]VB12修饰的透明质酸纳米粒可促进胰岛素跨过Caco-2细胞单层膜,且对糖尿病大鼠的口服降糖作用优于胰岛素溶液.%[Objective] To investigate the effects of vitamin B12-conjugated hyaluronic nanoparticles on oral delivery of insulin. [Methods] Insulin loaded vitamin Bl2-conjugated hyaluronic nanoparticles (INS/VB12-HA NP) were prepared by a modified double-emulsion method. The particle size and Zeta potential measurements were carried out by photon correction spectroscopy. The insulin entrapment efficiency and loading efficiency were quantified by RP-HPLC. Caco-2 monolayer was applied as a cell model for the uptake and penetration experiment. Hypoglycemic effects of INS/VB12-HA NP on the blood glucose level of STZ- diabetic rats were evaluated. [Results] The particle size was in the range of 185—286 nm, and their PDI values were less than 0.25. The insulin entrapment efficiency was around 55%. The cellular uptake of INS/VB12-HA NP by Caco-2 cells was significantly higher than those of insulin solution after incubation 0.5h and in the insulin concentration of 25-200 μg/mL. The Caco-2 cell monolayer treating with INS/ VB12-HA NP for 4 h did not show any significant change in TEER. The VB12-HA NP transferred more insulin across the Caco-2 cell monolayer than insulin solution did. In vivo experiments, the INS/VB12-HA NP could reduce the blood glucose level of STZ- diabetic rats after oral administration. [Conclusion] Compared with insulin solution, VB12-HA NP enhanced the insulin through Caco-2 cell monolayer by transcellular pathway and showed strong hypoglycemic effects on STZ-diabetic rats.

著录项

  • 来源
    《中山大学学报(医学科学版)》|2012年第5期|597-602|共6页
  • 作者单位

    中山大学药学院,广东广州510006;

    广东省创新药物制剂工程技术研究开发中心,广东广州510006;

    中山大学药学院,广东广州510006;

    广东省创新药物制剂工程技术研究开发中心,广东广州510006;

    中山大学药学院,广东广州510006;

    广东省创新药物制剂工程技术研究开发中心,广东广州510006;

    中山大学药学院,广东广州510006;

    广东省创新药物制剂工程技术研究开发中心,广东广州510006;

    中山大学药学院,广东广州510006;

    广东省创新药物制剂工程技术研究开发中心,广东广州510006;

    中山大学药学院,广东广州510006;

    广东省创新药物制剂工程技术研究开发中心,广东广州510006;

  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 生物药剂学;
  • 关键词

    口服胰岛素; 维生素B12; 透明质酸纳米粒; 降糖作用;

  • 入库时间 2023-07-25 17:00:33

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号